GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $339,605,000 | +85.0% | 7,801,625 | +85.1% | 0.04% | +76.0% |
| Q1 2022 | $183,598,000 | -3.4% | 4,214,828 | -2.2% | 0.02% | +8.7% |
| Q4 2021 | $190,108,000 | +16.7% | 4,310,825 | +1.1% | 0.02% | +4.5% |
| Q3 2021 | $162,862,000 | -3.2% | 4,262,277 | +0.9% | 0.02% | 0.0% |
| Q2 2021 | $168,221,000 | +18.2% | 4,224,551 | +5.9% | 0.02% | +4.8% |
| Q1 2021 | $142,335,000 | +1.9% | 3,988,121 | +5.1% | 0.02% | -4.5% |
| Q4 2020 | $139,629,000 | +9.8% | 3,794,274 | +12.3% | 0.02% | -12.0% |
| Q3 2020 | $127,133,000 | -5.5% | 3,377,618 | +2.4% | 0.02% | -16.7% |
| Q2 2020 | $134,523,000 | -21.2% | 3,297,940 | -26.8% | 0.03% | -34.8% |
| Q1 2020 | $170,630,000 | +7.4% | 4,503,300 | +33.2% | 0.05% | +24.3% |
| Q4 2019 | $158,876,000 | +7.5% | 3,381,076 | -2.3% | 0.04% | -5.1% |
| Q3 2019 | $147,727,000 | -4.0% | 3,461,259 | -10.0% | 0.04% | -4.9% |
| Q2 2019 | $153,912,000 | +1.4% | 3,845,882 | +5.8% | 0.04% | -4.7% |
| Q1 2019 | $151,853,000 | +25.3% | 3,633,716 | +14.5% | 0.04% | +19.4% |
| Q4 2018 | $121,225,000 | -28.4% | 3,172,600 | -24.7% | 0.04% | -14.3% |
| Q3 2018 | $169,232,000 | +16.1% | 4,212,892 | +16.5% | 0.04% | +7.7% |
| Q2 2018 | $145,742,000 | +23.4% | 3,615,525 | +19.6% | 0.04% | +18.2% |
| Q1 2018 | $118,129,000 | +18.9% | 3,023,503 | +7.9% | 0.03% | +22.2% |
| Q4 2017 | $99,381,000 | -36.2% | 2,801,812 | -26.9% | 0.03% | -42.6% |
| Q3 2017 | $155,688,000 | -13.7% | 3,834,695 | -8.4% | 0.05% | -14.5% |
| Q2 2017 | $180,433,000 | -47.5% | 4,184,425 | -48.7% | 0.06% | +3.8% |
| Q1 2017 | $343,878,000 | -3.2% | 8,156,520 | -11.6% | 0.05% | -8.6% |
| Q4 2016 | $355,394,000 | +82.5% | 9,228,586 | +104.4% | 0.06% | -13.4% |
| Q3 2016 | $194,757,000 | -2.3% | 4,515,572 | -1.8% | 0.07% | -6.9% |
| Q2 2016 | $199,345,000 | +10.1% | 4,599,591 | +3.0% | 0.07% | +2.9% |
| Q1 2016 | $181,032,000 | -7.3% | 4,464,437 | -7.8% | 0.07% | -1.4% |
| Q4 2015 | $195,287,000 | +11.1% | 4,839,818 | +5.8% | 0.07% | +9.2% |
| Q3 2015 | $175,835,000 | -19.3% | 4,573,080 | -12.6% | 0.06% | -14.5% |
| Q2 2015 | $217,870,000 | -2.0% | 5,230,970 | +8.6% | 0.08% | -7.3% |
| Q1 2015 | $222,327,000 | +24.4% | 4,817,471 | +15.2% | 0.08% | +26.2% |
| Q4 2014 | $178,716,000 | -10.0% | 4,181,462 | -3.2% | 0.06% | -14.5% |
| Q3 2014 | $198,536,000 | +19.3% | 4,318,816 | +38.7% | 0.08% | +16.9% |
| Q2 2014 | $166,473,000 | +7.5% | 3,112,802 | +7.4% | 0.06% | 0.0% |
| Q1 2014 | $154,914,000 | -9.2% | 2,899,384 | -9.2% | 0.06% | -11.0% |
| Q4 2013 | $170,557,000 | +20.7% | 3,194,564 | +13.4% | 0.07% | +9.0% |
| Q3 2013 | $141,334,000 | +3.0% | 2,817,100 | +2.6% | 0.07% | -2.9% |
| Q2 2013 | $137,202,000 | – | 2,745,680 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |